People channel feed

Nex­Im­mune to lay off 53% of em­ploy­ees to save mon­ey, CFO to step down 

Last year

Sana lays off staff as cell ther­a­py biotech awaits first clin­i­cal da­ta

Last year
Cell/Gene Tx

Sage re­mains tight-lipped on post­par­tum launch plans in wake of re­struc­tur­ing

Last year
Pharma

Sage shrinks work­force by 40% in light of ma­jor de­pres­sion drug re­jec­tion 

Last year
R&D

Sanofi taps se­r­i­al biotech in­vestor, en­tre­pre­neur as R&D chief — while pro­mot­ing busi­ness op­er­a­tions, dig­i­tal lead­ers

Last year
Pharma

Charles Riv­er Lab­o­ra­to­ries to lay off 55 em­ploy­ees in Cal­i­for­nia

Last year
Discovery
Manufacturing

Cell ther­a­py start­up Notch Ther­a­peu­tics clos­es one of three sites

Last year
Startups
Cell/Gene Tx

Apel­lis trims staff, shrinks R&D plans to save mon­ey in face of loom­ing com­pe­ti­tion in oph­thal­mol­o­gy

Last year
R&D
Pharma

i2o Ther­a­peu­tics clos­es $46M Se­ries A, names Kurt Graves as CEO and ac­quires Intar­cia’s twice-re­ject­ed di­a­betes as­set

Last year
Financing
Startups

Bax­ter CD­MO Bio­Phar­ma So­lu­tions names Fran­co Ne­gron as CEO ahead of pro­posed sale

Last year
Manufacturing

Agenus to trim its staff num­bers and as­sets

Last year
R&D

No­var­tis to cut 103 clin­i­cal work­ers in New Jer­sey

Last year

La­va Ther­a­peu­tics makes cuts to its head­count

Last year
R&D

Ar­a­vive warns of pos­si­ble liq­ui­da­tion as it ax­es all clin­i­cal work, lays off 70% of em­ploy­ees

Last year
R&D

Ex-em­ploy­ees of Ra­maswamy's in­vest­ment com­pa­ny sue, claim­ing they were mis­led or pushed to vi­o­late se­cu­ri­ties law

Last year
Law

The End­points Slack In­ter­view: NewLim­it's Ja­cob Kim­mel brings an­ti-ag­ing back to re­al­i­ty

Last year

Af­ter Prometheus sale, Mark McKen­na heads to an­oth­er au­toim­mune biotech as chair of Apogee

Last year

Bay­er's cell ther­a­py unit Blue­Rock Ther­a­peu­tics lays off about 50 em­ploy­ees

Last year
Cell/Gene Tx

Q&A: FDA's Pe­ter Marks ready to en­cour­age more ac­cel­er­at­ed ap­provals for rare dis­eases

Last year
FDA+

Bris­tol My­ers to cut 108 em­ploy­ees in New Jer­sey

Last year
Pharma

Ex­clu­sive: CSO George Yan­copou­los talks Re­gen­eron’s next chap­ter of ge­net­ics, weight loss drugs, and Alzheimer's

Last year
R&D

Alaunos’ run­way ends be­fore New Year's, as TCR biotech shrinks staff, seeks sale

Last year
R&D

Ther­mo Fish­er Sci­en­tif­ic to trim staff by more than 200 at Flori­da site

Last year
Manufacturing

BioX­cel lays off 100 em­ploy­ees as it looks to change up its strat­e­gy

Last year
R&D
First page Previous page 21222324252627 Next page Last page
A service from the Financial Times